The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2377–2400 of 3,535
Pharvaris has presented new data on **deucrictibant**, a novel oral bradykinin B2 receptor antagonist, at the Consortium of Independent Immunology Clinics Sprin...
Silo Pharma, Inc. has announced the advancement of its lead program, **SPC-15**, an intranasal treatment targeting **post-traumatic stress disorder (PTSD)**. Th...
**ATF5 has been identified as a critical regulator in the trade-off between muscle mass and muscle quality during aging. Research conducted on ATF5 knockout (KO...
Mitrix Bio has recently reported **preliminary Phase 1 safety results** for its innovative approach to mitochondrial transplantation, marking a significant step...
Seragon Biosciences has unveiled promising preclinical results for **SRN-901**, an oral combinatorial longevity drug, demonstrating significant physiological be...
Cala Health has received FDA clearance for the **Cala kIQ Plus system**, a next-generation wearable neurostimulation device aimed at alleviating **action hand t...
AliveCor has achieved CE Mark certification for its **Kardia 12L electrocardiogram system**, enabling its distribution throughout the European Economic Area. Th...
Omada Health's recent 12-week comparative study demonstrates that participants enrolled in its **GLP-1 Care Track** program exhibit significantly greater weight...
Une étude préclinique menée par **Nanobiotix** a démontré l'efficacité de sa technologie **nanoprimer** pour améliorer la biodisponibilité des thérapies basées...
Nanobiotix has presented promising preclinical data on its **Nanoprimer** platform, which aims to enhance the efficacy of lipid nanoparticle (LNP)-delivered the...
A recent cross-sectional study involving **5,068 urban adults aged ≥50 years** in Brazil has elucidated the interplay between **intrinsic capacity** and **neigh...
**Coronary arterial age (CAA)**, derived from coronary artery calcium (CAC) percentiles, has been evaluated for its prognostic significance in a cohort of 1,482...
A study shows that aromatherapy can enhance sleep quality and cognitive function in older adults.
A recent **randomized controlled trial** conducted in Istanbul has demonstrated that a **circadian-aligned aromatherapy protocol** can significantly enhance sle...
A recent retrospective cohort study utilizing the Clinical Practice Research Datalink (Aurum) database has revealed significant disparities in the provision of...
**Perioperative myocardial injury/infarction (PMI) significantly impacts older patients undergoing major noncardiac surgery, as demonstrated in a multicenter pr...
Monopar Therapeutics has announced promising results from the **Phase 3 FoCus trial** of **ALXN1840 (tiomolibdate choline)**, demonstrating significant neurolog...
**KIMMTRAK (tebentafusp-tebn) demonstrates a significant advancement in the treatment of metastatic uveal melanoma (mUM), effectively doubling the five-year ove...
Xenon Pharmaceuticals has presented compelling data from the Phase 3 **X-TOLE2 study** at the American Academy of Neurology (AAN) Annual Meeting, showcasing the...
Revolution Medicines, Inc. has presented updated Phase 1 clinical data for **zoldonrasib**, a selective oral inhibitor targeting the **KRAS G12D** mutation, at...
Molecular Partners AG has introduced **MP0632**, the first logic-gated Switch-DARPin T cell engager candidate targeting solid tumors that co-express **mesotheli...
Researchers are uncovering the **preclinical stage of rheumatoid arthritis (RA)**, a critical window that could enable early identification and intervention for...
Recent research has identified a promising therapeutic avenue for addressing biological aging through **retrotransposon suppression**. A study published in an o...
A recent study led by researchers from the Universitat Rovira i Virgili reveals that **extra virgin olive oil (EVOO)** may enhance cognitive function through it...
